US agency accuses L'Oreal of misleading marketing
WASHINGTON (AFP) - United States (US) regulators accused French cosmetics giant L'Oreal of misleading claims in marketing its Lancome line of anti-aging products, according to a letter released on Tuesday.
In the letter, addressed to the president of L'Oreal-owned Lancome USA, the Food and Drug Administration (FDA) said some Lancome products advertised online carry claims that "are intended to affect the structure or any function of the human body, rendering them drugs" under US law.
The products under scrutiny include the Genifique Youth Activating Concentrate, which claims to boost "the activity of genes and stimulates the production of youth proteins", according to the letter.
Another singled out is the Genifique Repair Youth Activating Night Cream, which claims to boost "the activity of genes".